期刊文献+

NPS R-467对甲状旁腺细胞分泌甲状旁腺激素的作用 被引量:5

Effect of NPS R-467 on PTH secretion of cultured parathyroid cells from secondary hyperparathyroidism patients
原文传递
导出
摘要 目的 观察钙受体 (CaR)激动剂NPSR 46 7对严重继发性甲状旁腺功能亢进 (SHPT)患者甲状旁腺细胞分泌甲状旁腺激素 (PTH)功能的影响。方法 对严重SHPT患者手术切除的甲状旁腺组织进行细胞培养。在培养 90min时加入NPSR 46 7及其异构体NPSS 46 7,后者作为阴性对照。药物的终浓度分别为 2 5、5 0和 10 0nmol/L ,用放免法检测加药 15、30、6 0min后培养上清液中PTH的分泌量。结果 加药 15min后 ,NPSR 46 7组和阴性对照组PTH的分泌值非常接近 ,约为 1 8ng/10 5细胞。随后NPSS 46 7组PTH的测定值呈上升趋势 ,加药 6 0min后达 2 3ng/10 5细胞 ,而NPSR 46 7组在加药 30min后降为对照组的 80 % ,加药 6 0min后降为对照组的 6 0 % ,不同剂量组间NPSR 46 7的效应无明显差异。结论 CaR激动剂NPSR 46 7能明显抑制重症SHPT患者甲状旁腺细胞PTH的分泌 。 Objective To observe the effect of NPS R 467, a calcimimetic, on PTH secretion of cultured parathyroid cells from severe secondary hyperparathyroidism (SHPT) patient. Methods The parathyroid tissue from a severe SHPT patient (iPTH: 2 000 pg/ml) who had underwent parathyroidectomy was cultured in medium containing 1.05 mmol/L Ca and 0.8 mmol/L Mg. After 90 minutes′ culture, NPS R 467 or NPS S 467, as negative control, with the final concentrations of 25, 50, and 100 nmol/L was added. The supernatant of medium was aspirated after 15, 30, and 60 minutes and iPTH therein was measured by radioimmunoassay. Results There was no difference between the PTH concentrations in NPS R 467 group and NPS S 467 15 minutes after the reagents were added (1.8 ng/10 5 cells). In the NPS S 467 group, the PTH secretion was elevated along with the culture time, at 60 minutes up to 2.3 ng/10 5 cells. The PTH concentration of NPS R 467 was 80% of that of control group 30 minutes later and 60% of that in control group 60 munites later. No difference was found among the effects of NPS R 467 at different concentrations. Conclusion The calcimimetic NPS R 467 significantly suppresses the PTH secretion, even in severe uremic hyperparathyroidisim patient. It is an effective medicine for hyperparathyroidism.
出处 《中华医学杂志》 CAS CSCD 北大核心 2001年第21期1321-1323,共3页 National Medical Journal of China
基金 国家自然科学基金资助项目 ( 30 0 70 35 2 )
关键词 钙通道激动药 甲状旁腺功能亢进症 继发性 细胞培养 甲状旁腺激素 NPSR-467 Calcimimetics Hyperparathyroidism, secondary Cell culture Parathyroid hormone
  • 相关文献

参考文献2

二级参考文献2

共引文献8

同被引文献33

  • 1王宁宁,王笑云,彭韬,吴宏飞,胡建明,赵卫红,俞香宝.Expression of the calcium receptor CaR in the parathyroid of secondary hyperparathyroidism patients[J].Chinese Medical Journal,2004(9):1408-1410. 被引量:1
  • 2李海明,顾勇,薛骏,李铭新,陈靖,陆福明,王红鹰,邹强.甲状旁腺全切除加前臂移植治疗尿毒症继发性甲状旁腺功能亢进[J].中华肾脏病杂志,2006,22(4):197-200. 被引量:40
  • 3胡建明,吴宏飞,王笑云,俞香宝,赵奕华,沈霞,刘佳,孙彬,邢昌赢,杨俊伟.肾性甲状旁腺功能亢进症甲状旁腺全切加前臂移植31例临床分析[J].中华内科杂志,2006,45(9):714-716. 被引量:28
  • 4Wajeh Y, Qunibi: Introduction. Kidney Int,2004, 66 (suppl.90):S1
  • 5National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis, 2002(suppl 1) ,39:S1 - S266
  • 6National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. (Draft),2003,5 - 195
  • 7Cohen. Eric. ASN annual meeting, 2003, p597 - 632
  • 8L.C. Fredric and J. F. Murray. Disorders of Bone and Mineral Metabolism. 2nd ed, 2002, LWW. COM. p3 - 157
  • 9Wang Xiao Yun, Sun Bin, Zhou Fu Hua. Vitmin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients. Chinese Medical J,2001,114(4):410 - 414
  • 10Goldsmith D, Kothawala P, Chalian A, et al. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD. Am J Kidney Dis, 2009,53 (6) : 1002-1013.

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部